Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2008
12/02/2008US7459482 Agent for treatment of cisplatin-resistant cancer
12/02/2008US7459441 Remedies for dry eye and diseases associated with dry eye
12/02/2008US7459440 Ocular tear growth factor-like protein
12/02/2008US7459436 Administering erythropoietin or derivative to treat diabetes
12/02/2008US7459431 Recombinant gelatin-like proteins for use as plasma expanders
12/02/2008US7459307 Composition for treatment of articular cartilage damage
12/02/2008US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/02/2008US7459272 In order to produce lytic infections in pathogenic bacteria to prevent infection, especially post-surgery
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008US7459164 Composition for therapeutic and cosmetic botulinum toxin
12/02/2008US7459154 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
12/02/2008US7459151 Phosphate-binding polymers for oral administration
12/02/2008US7459146 Nanoparticles; administering drugs; mixture with excipients, propellants; stability; respiratory system disorders
12/02/2008US7459142 High viscosity embolizing compositions comprising prepolymers
12/02/2008US7458982 Photokinetic delivery of biologically active substances using pulsed incoherent light
12/02/2008CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/02/2008CA2433812C A method for producing tablets from plant extracts
12/02/2008CA2397404C Micronized freeze-dried particles
12/02/2008CA2381203C Formulations for treating or preventing mucositis
12/02/2008CA2359646C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
12/02/2008CA2346631C Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2341624C Stable spray-dried protein formulations
12/02/2008CA2340224C Nimesulide containing topical pharmaceutical compositions
12/02/2008CA2338337C Foamable formulation and foam
12/02/2008CA2335485C Oregano for the treatment of internal parasites and protozoa
12/02/2008CA2335179C Tablet and process for making the same
12/02/2008CA2334022C Contaminant reduced marine oil
12/02/2008CA2306371C Use of flunarizine for the topical treatment of glaucoma
12/02/2008CA2269780C Polyanionic polymers as adjuvants for mucosal immunization
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/02/2008CA2172507C Methods and compositions for microencapsulation of antigens for use as vaccines
12/02/2008CA2151219C Thermostable non-reducing saccharide-forming enzyme, its production and uses
12/02/2008CA2136434C Erythropoietin drug delivery system
11/2008
11/27/2008WO2008144565A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
11/27/2008WO2008144185A2 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
11/27/2008WO2008143957A2 Hydrogel materials
11/27/2008WO2008143812A2 Biologic devices for hemostasis
11/27/2008WO2008143705A2 Methods and compositions for rapid inactivation of proteins
11/27/2008WO2008143682A1 Colored esmolol concentrate
11/27/2008WO2008143339A1 Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate
11/27/2008WO2008143241A1 Method for producing pharmaceutical tablet
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008142316A1 Cyclodextrine oligomers as vectors of activated molecules
11/27/2008WO2008142231A2 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008WO2008142090A1 Self-emulsifying formulation of tipranavir for oral administration
11/27/2008WO2008141762A2 Polymer conjugate compounds for the inhibition of apoptosis
11/27/2008WO2008141507A1 Organic solvent-free gellan gum and its preparing method thereof
11/27/2008WO2008141496A1 Sustained-release system for epo and gm-csf
11/27/2008WO2008141475A1 A simple method of introducing magnetic particles into macromolecule
11/27/2008WO2008141449A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof
11/27/2008WO2008141357A1 Dendritic molecules
11/27/2008WO2008120181A3 A method of producing fast dissolving tablets
11/27/2008WO2008109031A8 Liposome carriers for in vivo delivery of fullerenes
11/27/2008WO2008106571A3 Sustained release parenteral formulations of buprenorphine
11/27/2008WO2008106503A3 Discrete size and shape specific pharmaceutical organic nanoparticles
11/27/2008WO2008099016A3 Method for stabilising blood plasma components in a lyophilisate
11/27/2008WO2008096804A8 Eye drop preparation comprising latanoprost
11/27/2008WO2008094910A3 Hyaluronate compositions
11/27/2008WO2008094693A8 Compositions for aerosolization of highly conductive solutions
11/27/2008WO2008087489A8 Treating cancer using electromagnetic fields in combination with other treatment regimens
11/27/2008WO2008080037A3 Carotenoids of enhanced bioavailability
11/27/2008WO2008075191A3 Gas-filled microvesicles with targeting ligand in respect of fc-region of an antibody or therapeutic agent
11/27/2008WO2008039472A3 Stabilizing compositions for antibiotics and methods of use
11/27/2008WO2008036299A3 Edible water-soluble film containing a foam reducing flavoring agent
11/27/2008WO2008011114A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/27/2008WO2008006544A3 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition
11/27/2008WO2007121471A3 Dialkyl ether delivery agents
11/27/2008WO2007039864A3 The staudinger reaction in imaging and therapy and kits for use in imaging and therapy
11/27/2008US20080293829 Novel Compounds
11/27/2008US20080293828 Use of Copolymers as Solubilizers For Slightly Water-Soluble Compounds
11/27/2008US20080293827 Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same
11/27/2008US20080293817 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
11/27/2008US20080293805 Drug delivery system and the preparing method thereof
11/27/2008US20080293803 Melatonin daily dosage units
11/27/2008US20080293703 Topical Preparation and Method for Transdermal Delivery and Localization of Therapeutic Agents
11/27/2008US20080293686 Semi-solid systems containing azetidine derivatives
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293624 Stabilized FGF formulations containing reducing agents
11/27/2008US20080293617 Implantable Putty Material
11/27/2008US20080292714 Bone targeting of degradable drug filled nanoparticles
11/27/2008US20080292712 Methods and compositions for enhanced delivery of bioactive molecules
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292702 Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same
11/27/2008US20080292701 Lansoprazole dosage forms; fast disintegration in the oral cavity even without water
11/27/2008US20080292688 Liposome and preparation method of the same
11/27/2008US20080292666 Preparation for Preventing or Treating Calcium Deficiency Conditions In Mammals
11/27/2008US20080292664 Hydrogels and Hyaluronic Acid and Alpha, Beta-Polyaspartyl-Hydrazide and Their Biomedical and Pharmaceutical Uses
11/27/2008US20080292663 Adjuvant compositions and methods for delivering vaccines
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292606 Pharmaceutical Oral Dosage Form Comprising a Non-Steroidal Anti-Inflammatory Drug, and Having Good Palatability
11/27/2008US20080292580 Treatment of Inflammatory Diseases
11/27/2008US20080292563 Inhalable Powder Containing Tiotropium
11/27/2008CA2688554A1 Dose forms comprising vx-950 and their dosage regimen
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2688146A1 Antibodies to il-6 and use thereof
11/27/2008CA2687956A1 Method for producing pharmaceutical tablet
11/27/2008CA2687630A1 Self-emulsifying formulation of tipranavir for oral administration
1 ... 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 ... 1712